Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.
Company Details
- Employees
- 59
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://dispatchbio.com
Dispatch Bio Questions
Dispatch Bio's website is https://dispatchbio.com
Dispatch Bio's LinkedIn profile is https://www.linkedin.com/company/dispatch-bio
Dispatch Bio has
59 employees.
View email and phone details for 59
employees at Dispatch Bio.
Dispatch Bio's industry is
Biotechnology Research
Dispatch Bio's top competitors are
Parallel Bio,
Proscia,
Infinity Bio, Inc.,
Olaris, Inc,
Epicrispr Biotechnologies,
Maplight Therapeutics, Inc.,
Prellis Biologics,
Matterworks,
Arbor Biotechnologies,
Stealth Mode Biotech.
Dispatch Bio's categories are Biotechnology Research
Dispatch Bio's founding year is 2022
